Emerging opportunities include advancements in mRNA and viral vector technologies for rapid development, improved distribution through digital tracking, and public-private partnerships enhancing ...

HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...

Doctors and scientists who spoke to HuffPost are worried for a multitude of reasons and want you to know that this will ...

Robert F. Kennedy Jr.’s ‘Make America Healthy Again’ movement is taking off in red — and blue — states, even as health ...

When HHS Secretary Robert Kennedy Jr. terminated nearly $500 million in mRNA research last week, he didn’t just cripple our ...

Canceling federal mRNA vaccine projects threatens much more than pandemic response, according to Michigan State University’s Director of the Precision Health Program ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...

AN2 Therapeutics completes dosing first single ascending dose cohort in phase 1 first-in-human clinical trial of oral AN2-502998 for Chagas disease: Menlo Park, California Thursda ...

Researchers have controlled the evolution of E. coli bacteria in the lab in order to dramatically increase the amount of ...